Subsequently, this can further suppress tumor progression by inhibiting the JAK/STAT signaling pathway and other related pathways, restoring the tumoricidal capabilities of immune cells, including CD8+ T cells, and regulating the tumor microenvironment. Here, CD8A is linked to neoplasm.